Application of directional customized corneal relaxing incision in EVO ICL implantation: high myopia with low astigmatism
Abstract
Purpose: To evaluate the efficacy of EVO-ICL implantation combined with a corneal relaxing incision for the correction of moderate to high myopia with low astigmatism.
Design: Prospective non-randomized clinical trial.
Methods: This study included 35 eyes of 35 patients with astigmatism corrected by corneal relaxing incision (CRI) on the steep meridian and 30 eyes of 30 patients who underwent conventional temporal incision as controls. Visual acuity, refractive parameters, keratometry, corneal astigmatism, and corneal aberration were measured preoperatively and 1 and 3 months postoperatively.
Results: The refractive astigmatism of the CRI group decreased significantly from 0.89 ± 0.22 preoperatively to 0.39 ± 0.25 D at 1 month and 0.35 ± 0.30 D at 3 months postoperatively, and from 0.46 ± 0.32 D to 0.45 ± 0.34 D and 0.44 ± 0.30 D in the control group, respectively (P < 0.001). The preoperative anterior corneal astigmatism of the CRI group was significantly higher than the control group (P < 0.001) and decreased significantly from 1.03 ± 0.32 D preoperatively to 0.74 ± 0.36 D at 1 month and 0.69 ± 0.39 D at 3 months postoperatively (P < 0.001). The preoperative posterior corneal astigmatism of the CRI group decreased significantly from 0.32 ± 0.11 D preoperatively to 0.28 ± 0.12 D at 1 month and 0.25 ± 0.10 D at 3 months postoperatively (P < 0.001). There were significant differences in the postoperative RMS of trefoil aberration and total HOAs of the whole cornea, anterior…
How strong is the evidence?
Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 35 participants or records.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.